NEULAND LABS Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Quarterly Results    (NELB)

Here are the latest quarterly results of NEULAND LABS. For more details, see the NEULAND LABS financial fact sheet and NEULAND LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

NEULAND LABS Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
3
Sep-20
3
Dec-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,7271,8101,8622,0361,9192,0542,4142,454 
Other income Rs m13561018762 
Turnover Rs m1,7401,8151,8682,0461,9362,0612,4202,456 
Expenses Rs m1,5431,6241,6141,7561,6191,7172,0061,989 
Gross profit Rs m184186248281300337408465 
Depreciation Rs m69768378768993104 
Interest Rs m4740485771543544 
Profit before tax Rs m8175123156171202286319 
Tax Rs m14193845264517252 
Profit after tax Rs m675686110-94151213267 
Gross profit margin %10.710.313.313.815.616.416.919.0 
Effective tax rate %16.825.230.529.1154.825.525.316.3 
Net profit margin %3.93.14.65.4-4.97.38.810.9 
Diluted EPS Rs 5.2 4.4 6.7 8.6 -7.3 11.7 16.6 20.8  
Diluted EPS (TTM) Rs NA 16.6 19.9 24.9 12.4 19.7 29.7 41.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: NEULAND LABS 3QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  STRIDES PHARMA SCIENCE  LUPIN  

Compare NEULAND LABS With:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  STRIDES PHARMA SCIENCE  LUPIN  

Compare NEULAND LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Views on news

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading? (Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NEULAND LABS SHARE PRICE


Mar 5, 2021 (Close)

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NEULAND LABS

NEULAND LABS 5-YR ANALYSIS

COMPARE NEULAND LABS WITH

MARKET STATS